N-[(Benzyloxy)carbonyl]-S-phenylcysteine(CAS: 82611-65-2)

N-[(Benzyloxy)carbonyl]-S-phenylcysteine (CAS: 82611-65-2) is subject to regulatory guidelines such as GHS classification for hazardous substances, REACH regulations for European manufacturers and importers, as well as FDA and EPA requirements for pharmaceutical and chemical usage. It is important to comply with local and international regulations to ensure safe handling and use.

Several alternatives to N-[(Benzyloxy)carbonyl]-S-phenylcysteine (CAS: 82611-65-2) exist in synthesis, including S-phenylcysteine methyl ester and S-phenylcysteine ethyl ester. These alternatives can be used as reagents in similar reactions and provide similar functionalities when appropriate.

The market for N-[(Benzyloxy)carbonyl]-S-phenylcysteine (CAS: 82611-65-2) is growing due to its applications in pharmaceuticals and research. Recent trends show increased interest in its use as a cysteine derivative in drug development and as a building block in peptide synthesis. Research is focusing on its potential as an anti-inflammatory agent and its role in cancer research.

Waste containing N-[(Benzyloxy)carbonyl]-S-phenylcysteine (CAS: 82611-65-2) should be collected in appropriate containers and handled according to local waste management regulations. Incineration or professional waste disposal services should be used for disposal. Ensure all waste is properly labeled and precautions are taken to prevent environmental contamination. Compliance with GHS guidelines and REACH regulations is crucial during waste handling and disposal.